Molecular diagnosis identified a fibronectin 1- fibroblast growth factor receptor 1 (FN1-FGFR1) gene fusion, encountered in over 50% of cases of phosphaturic mesenchymal tumors, therefore confirming the diagnosis. The gene discussed is FN1; the disease is mesenchymal cell neoplasm.